Search Results

Filter
  • 1-10 of  12 results for ""HIV Envelope Protein gp41""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity.

  • Authors : Xu L; Laboratory of Mucosal Entry of HIV-1 and Mucosal Immunity, Department of Infection, Immunity and Inflammation, Cochin Institute, CNRS UMR 8104, Paris, France.; INSERM U1016, Paris, France.

Subjects: Adjuvants, Immunologic*/Adjuvants, Immunologic*/Adjuvants, Immunologic*/chemistry ; Adjuvants, Immunologic*/Adjuvants, Immunologic*/Adjuvants, Immunologic*/pharmacology ; Antigens, Viral*/Antigens, Viral*/Antigens, Viral*/chemistry

  • Source: Frontiers in immunology [Front Immunol] 2021 Feb 03; Vol. 11, pp. 599278. Date of Electronic Publication: 2021 Feb 03 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41.

  • Authors : Duchemin M; Laboratory of Mucosal Entry of HIV-1 and Mucosal Immunity, Department of Infection, Immunity and Inflammation, Cochin Institute, CNRS UMR 8104, Paris, France.; INSERM U1016, Paris, France.

Subjects: HIV Antibodies/HIV Antibodies/HIV Antibodies/*immunology ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*immunology ; HIV Infections/HIV Infections/HIV Infections/*immunology

  • Source: Frontiers in immunology [Front Immunol] 2020 Jun 09; Vol. 11, pp. 1141. Date of Electronic Publication: 2020 Jun 09 (Print Publication: 2020).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Induction of Identical IgG HIV-1 Envelope Epitope Recognition Patterns After Initial HIVIS-DNA/MVA-CMDR Immunization and a Late MVA-CMDR Boost.

  • Authors : Joachim A; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.; Ahmed MIM

Subjects: AIDS Vaccines/AIDS Vaccines/AIDS Vaccines/*therapeutic use ; Epitopes/Epitopes/Epitopes/*immunology ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*immunology

  • Source: Frontiers in immunology [Front Immunol] 2020 Apr 28; Vol. 11, pp. 719. Date of Electronic Publication: 2020 Apr 28 (Print Publication: 2020).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure.

  • Authors : Ray K; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD, United States.

Subjects: Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Epitopes/Epitopes/Epitopes/*immunology ; HIV Antibodies/HIV Antibodies/HIV Antibodies/*immunology

  • Source: Frontiers in immunology [Front Immunol] 2019 Jul 05; Vol. 10, pp. 1512. Date of Electronic Publication: 2019 Jul 05 (Print Publication: 2019).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection.

  • Authors : Henrick BM; Evolve Biosystems, Davis, CA, United States.; Department of Food Science and Technology, University of Nebraska, Lincoln, NE, United States.

Subjects: HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*immunology ; HIV Infections/HIV Infections/HIV Infections/*immunology ; HIV-1/HIV-1/HIV-1/*immunology

  • Source: Frontiers in immunology [Front Immunol] 2019 Mar 15; Vol. 10, pp. 482. Date of Electronic Publication: 2019 Mar 15 (Print Publication: 2019).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines.

  • Authors : Wang L; BGI-Education Center, University of Chinese Academy of Sciences, Shenzhen, China.; BGI-Shenzhen, Shenzhen, China.

Subjects: AIDS Vaccines/AIDS Vaccines/AIDS Vaccines/*immunology ; B-Lymphocytes/B-Lymphocytes/B-Lymphocytes/*immunology ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*immunology

  • Source: Frontiers in immunology [Front Immunol] 2018 Sep 26; Vol. 9, pp. 2194. Date of Electronic Publication: 2018 Sep 26 (Print Publication: 2018).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.

  • Authors : Duchemin M; Laboratory of Mucosal Entry of HIV-1 and Mucosal Immunity, Department of Infection, Immunity and Inflammation, Cochin Institute, CNRS UMR 8104, Paris, France.; INSERM U1016, Paris, France.

Subjects: Antibody-Dependent Cell Cytotoxicity/Antibody-Dependent Cell Cytotoxicity/Antibody-Dependent Cell Cytotoxicity/*immunology ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*immunology ; HIV Infections/HIV Infections/HIV Infections/*prevention & control

  • Source: Frontiers in immunology [Front Immunol] 2018 Mar 29; Vol. 9, pp. 244. Date of Electronic Publication: 2018 Mar 29 (Print Publication: 2018).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print

Record details

×
Academic Journal

Vaccine-elicited and naturally elicited antibodies differ in their recognition of the HIV-1 fusion peptide.

  • Authors : Reveiz M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.; Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, United States.

Subjects: HIV-1*/HIV-1*/HIV-1*/immunology ; AIDS Vaccines*/AIDS Vaccines*/AIDS Vaccines*/immunology ; HIV Antibodies*/HIV Antibodies*/HIV Antibodies*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Nov 14; Vol. 15, pp. 1484029. Date of Electronic Publication: 2024 Nov 14 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure.

  • Authors : Umotoy JC; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam University Medical Center (UMC), Amsterdam Infection and Immunity Institute, University of Amsterdam, Amsterdam, Netherlands.; de Taeye SW

Subjects: Broadly Neutralizing Antibodies/Broadly Neutralizing Antibodies/Broadly Neutralizing Antibodies/*immunology ; HIV Antibodies/HIV Antibodies/HIV Antibodies/*immunology ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

  • Source: Frontiers in immunology [Front Immunol] 2021 Jul 01; Vol. 12, pp. 708806. Date of Electronic Publication: 2021 Jul 01 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  12 results for ""HIV Envelope Protein gp41""